1. World Health Organization. WHO global tuberculosis report 2014. http://www.who.int/tb/publications/global_report/en/. Accessed August 23, 2015.
2. Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States. MMWR Recomm Rep. 2010;59(RR-5):1-25.
3. Centers for Disease Control and Prevention. National shortage of purified-protein derivative tuberculin products. MMWR Morb Mortal Wkly Rep. 2013;62(16):312.
4. World Health Organization. Tuberculosis diagnostics: Xpert MTB/RIF test. http://www.who.int/tb/publications/Xpert_factsheet.pdf. Accessed 2015.
5. Lawn, SD. Diagnosis of pulmonary tuberculosis. Curr Opin Pulm Med. 2013,19(3):280-288.
6. Hall RG, Leff RD, Gumbo T. Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29(12):1468-1481.
7. Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60(48):1650-1653.
8. World Health Organization. The Treatment of Tuberculosis: Guidelines. 4th ed. Geneva, Switzerland: World Health Organization; 2010.
9. Luong Kv, Nguyen LT. Impact of vitamin D in the treatment of tuberculosis. Am J Med Sci. 2011;341(6):493-498.